The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive value of intratumoral signaling and immune infiltrate for response to preoperative (PO) trastuzumab (T) vs trastuzumab + everolimus (T+E) in patients (pts) with primary breast cancer (PBC): UNICANCER RADHER trial results.
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - Menarini; Novartis; SERVIER
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Isabelle Treilleux
No Relationships to Disclose
 
Julia Salleron
No Relationships to Disclose
 
Monica Arnedos
No Relationships to Disclose
 
Qing Wang
No Relationships to Disclose
 
Suzette Delaloge
Consulting or Advisory Role - Novartis; Roche (Inst)
Speakers' Bureau - Novartis; Roche
Research Funding - Novartis (Inst); Roche (Inst)
 
Delphine Loussouarn
No Relationships to Disclose
 
Jacques Bonneterre
No Relationships to Disclose
 
Maeva Lion
No Relationships to Disclose
 
Celine Mahier - Ait Oukhatar
Research Funding - Novartis (Inst)
 
Xavier Paoletti
No Relationships to Disclose
 
Maria Rios
No Relationships to Disclose
 
Veronique Dieras
Honoraria - Roche
Consulting or Advisory Role - Roche/Genentech
 
Marta Jimenez
Research Funding - Novartis (Inst)
 
Jean-Louis Merlin
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
 
Thomas Denis Bachelot
Consulting or Advisory Role - Novartis; Roche
Research Funding - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche